Various studies have shown that adjuvant treatment with fluorouracil, leucovorin, and oxaliplatin can improve overall survival in patients with stage II or III colon cancer. Additional studies have evaluated the duration of adjuvant chemotherapy and the use of pembrolizumab and bevacizumab as adjuvant treatments for colon cancer.